Back to Journals » Journal of Hepatocellular Carcinoma » Volume 10

Original Research

Early Tumor Marker Response Predicts Treatment Outcomes in Patients with Unresectable Hepatocellular Carcinoma Receiving Combined Lenvatinib, Immune Checkpoint Inhibitors, and Transcatheter Arterial Chemoembolization Therapy

       
Total article views   HTML views PDF downloads Totals
792 Dovepress* 689+ 29 718
PubMed Central* 103 59 162
Totals 792 88 880
*Since 12 October 2023

View citations on PubMed Central and Google Scholar